Patent holdings for IPC class A61K 47/02

Total number of patents in this class: 7812

10-year publication summary

534
643
641
712
781
894
820
736
706
651
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Axsome Therapeutics, Inc.
276
110
Takeda Pharmaceutical Company Limited
2713
43
The Regents of the University of California
20211
40
Hikma Pharmaceuticals USA Inc.
154
38
Azurity Pharmaceuticals, Inc.
213
35
Allergan, Inc.
2319
31
Sydnexis, Inc.
53
31
Hisamitsu Pharmaceutical Co., Inc.
780
29
Santen Pharmaceutical Co., Ltd.
601
29
Shionogi & Co., Ltd.
840
26
Xeris Pharmaceuticals, Inc.
108
26
Amgen Inc.
4147
25
Baxter International Inc.
2417
24
Eli Lilly and Company
3880
24
Novo Nordisk A/S
2273
24
Arecor Limited
104
23
Rohto Pharmaceutical Co., Ltd.
387
23
Sun Pharmaceutical Industries Limited
745
23
Eisai R&D Management Co., Ltd.
1214
23
Merck Sharp & Dohme LLC
3739
23
Other owners 7162